Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $59.57 in the prior trading day, Procept BioRobotics Corp (NASDAQ: PRCT) closed at $57.59, down -3.32%. In other words, the price has decreased by -$3.32 from its previous closing price. On the day, 0.98 million shares were traded. PRCT stock price reached its highest trading level at $62.9 during the session, while it also had its lowest trading level at $57.0.
Ratios:
Our goal is to gain a better understanding of PRCT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.01 and its Current Ratio is at 9.07. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 02, 2024, initiated with a Overweight rating and assigned the stock a target price of $105.
On November 14, 2024, Jefferies started tracking the stock assigning a Hold rating and target price of $95.
On August 11, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $42.Piper Sandler initiated its Overweight rating on August 11, 2023, with a $42 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 06 ’25 when Nouri Alaleh sold 3,641 shares for $61.31 per share. The transaction valued at 223,230 led to the insider holds 61,789 shares of the business.
Shiblaq Hisham sold 3,588 shares of PRCT for $219,980 on Mar 06 ’25. The EVP, Chief Comm. Officer now owns 63,380 shares after completing the transaction at $61.31 per share. On Mar 06 ’25, another insider, Waters Kevin, who serves as the EVP, CFO of the company, sold 3,662 shares for $61.31 each. As a result, the insider received 224,517 and left with 108,724 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 3157008896 and an Enterprise Value of 2905533952. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.06 while its Price-to-Book (P/B) ratio in mrq is 7.83. Its current Enterprise Value per Revenue stands at 12.942 whereas that against EBITDA is -31.796.
Stock Price History:
The Beta on a monthly basis for PRCT is 1.07, which has changed by 0.2075907 over the last 52 weeks, in comparison to a change of 0.087141395 over the same period for the S&P500. Over the past 52 weeks, PRCT has reached a high of $103.81, while it has fallen to a 52-week low of $45.56. The 50-Day Moving Average of the stock is -19.36%, while the 200-Day Moving Average is calculated to be -22.91%.
Shares Statistics:
The stock has traded on average 873.77K shares per day over the past 3-months and 1074490 shares per day over the last 10 days, according to various share statistics. A total of 54.72M shares are outstanding, with a floating share count of 51.84M. Insiders hold about 5.43% of the company’s shares, while institutions hold 92.02% stake in the company. Shares short for PRCT as of 1740700800 were 5079251 with a Short Ratio of 5.81, compared to 1738281600 on 5980863. Therefore, it implies a Short% of Shares Outstanding of 5079251 and a Short% of Float of 12.47.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
